[HTML][HTML] Acetylcholinesterase inhibitors in the treatment of neurodegenerative diseases and the role of acetylcholinesterase in their pathogenesis

ŁJ Walczak-Nowicka, M Herbet - International journal of molecular …, 2021 - mdpi.com
Acetylcholinesterase (AChE) plays an important role in the pathogenesis of
neurodegenerative diseases by influencing the inflammatory response, apoptosis, oxidative …

Status of acetylcholinesterase and butyrylcholinesterase in Alzheimer's disease and type 2 diabetes mellitus

G Mushtaq, NH Greig, JA Khan… - CNS & Neurological …, 2014 - ingentaconnect.com
Both Alzheimer's disease (AD) and Type 2 diabetes mellitus (T2DM) share the presence of
systemic and neuro-inflammation, enhanced production and accumulation of β-amyloid …

[HTML][HTML] Recurrent herpes simplex virus-1 infection induces hallmarks of neurodegeneration and cognitive deficits in mice

G De Chiara, R Piacentini, M Fabiani… - PLoS …, 2019 - journals.plos.org
Herpes simplex virus type 1 (HSV-1) is a DNA neurotropic virus, usually establishing latent
infections in the trigeminal ganglia followed by periodic reactivations. Although numerous …

[HTML][HTML] Huperzine A and its neuroprotective molecular signaling in Alzheimer's disease

MJ Friedli, NC Inestrosa - Molecules, 2021 - mdpi.com
Huperzine A (HupA), an alkaloid found in the club moss Huperzia serrata, has been used for
centuries in Chinese folk medicine to treat dementia. The effects of this alkaloid have been …

The significance of the cholinergic system in the brain during aging and in Alzheimer's disease

R Schliebs, T Arendt - Journal of neural transmission, 2006 - Springer
Acetylcholine is widely distributed in the nervous system and has been implicated to play a
critical role in cerebral cortical development, cortical activity, controlling cerebral blood flow …

A review on tacrine-based scaffolds as multi-target drugs (MTDLs) for Alzheimer's disease

B Sameem, M Saeedi, M Mahdavi, A Shafiee - European journal of …, 2017 - Elsevier
Alzheimer's disease (AD) is a multifactorial neurological disorder among elderly people and
combinatorial factors such as genetic, lifestyle, and environmental are involved in onset and …

Adenosine A2A receptor blockade prevents synaptotoxicity and memory dysfunction caused by β-amyloid peptides via p38 mitogen-activated protein kinase pathway

PM Canas, LO Porciúncula, GMA Cunha… - Journal of …, 2009 - Soc Neuroscience
Alzheimer's disease (AD) is characterized by memory impairment, neurochemically by
accumulation of β-amyloid peptide (namely Aβ1-42) and morphologically by an initial loss of …

The multifactorial nature of Alzheimer's disease for developing potential therapeutics

M Carmo Carreiras, E Mendes… - Current topics in …, 2013 - ingentaconnect.com
Alzheimerβs disease (AD) is a multifactorial neurodegenerative disorder with several target
proteins contributing to its aetiology. Pathological, genetic, biochemical, and modeling …

Activation of Wnt signaling by lithium and rosiglitazone reduced spatial memory impairment and neurodegeneration in brains of an APPswe/PSEN1ΔE9 mouse model …

EM Toledo, NC Inestrosa - Molecular psychiatry, 2010 - nature.com
Alzheimer's disease (AD) is a neurodegenerative disorder characterized by a progressive
deterioration of cognitive abilities, accumulation of the amyloid-β-peptide (Aβ) and synaptic …

Novel tacrine− 8-hydroxyquinoline hybrids as multifunctional agents for the treatment of Alzheimer's disease, with neuroprotective, cholinergic, antioxidant, and copper …

MI Fernández-Bachiller, C Pérez… - Journal of medicinal …, 2010 - ACS Publications
Tacrine and PBT2 (an 8-hydroxyquinoline derivative) are well-known drugs that inhibit
cholinesterases and decrease β-amyloid (Aβ) levels by complexation of redox-active metals …